Mouse models of abdominal aortic aneurysms - PubMed (original) (raw)
Review
Mouse models of abdominal aortic aneurysms
Alan Daugherty et al. Arterioscler Thromb Vasc Biol. 2004 Mar.
Abstract
Many mouse models of abdominal aortic aneurysms have been developed that use a diverse array of methods for producing the disease, including genetic manipulation and chemical induction. These models could provide insight into potential mechanisms in the development of this disease. Although experimental studies on abdominal aortic aneurysms (AAAs) have used a variety of mammalian and avian approaches, there is an increasing reliance on the use of mice. The models recapitulate some facets of the human disease including medial degeneration, inflammation, thrombus formation, and rupture. Most of the mouse models of AAA are evoked either by genetically defined approaches or by chemical means. The genetic approaches are spontaneous and engineered mutations. These include defects in extracellular matrix maturation, increased degradation of elastin and collagen, aberrant cholesterol homeostasis, and enhanced production of angiotensin peptides. The chemical approaches include the intraluminal infusion of elastase, periaortic incubations of calcium chloride, and subcutaneous infusion of AngII. A common feature of these models is the reduction of AAA incidence and severity by the prophylactic administration of matrix metalloproteinase (MMP) inhibitors or genetically engineered deficiencies of specific members of this proteolytic protein family. The validation of mouse models of AAAs will provide insight into the mechanisms of progression of the human disease.
Similar articles
- Comparison of cell-type-specific vs transmural aortic gene expression in experimental aneurysms.
Sho E, Sho M, Nanjo H, Kawamura K, Masuda H, Dalman RL. Sho E, et al. J Vasc Surg. 2005 May;41(5):844-52. doi: 10.1016/j.jvs.2005.02.027. J Vasc Surg. 2005. PMID: 15886670 - Differential effects of doxycycline, a broad-spectrum matrix metalloproteinase inhibitor, on angiotensin II-induced atherosclerosis and abdominal aortic aneurysms.
Manning MW, Cassis LA, Daugherty A. Manning MW, et al. Arterioscler Thromb Vasc Biol. 2003 Mar 1;23(3):483-8. doi: 10.1161/01.ATV.0000058404.92759.32. Epub 2003 Jan 30. Arterioscler Thromb Vasc Biol. 2003. PMID: 12615694 - Adventitial mast cells contribute to pathogenesis in the progression of abdominal aortic aneurysm.
Tsuruda T, Kato J, Hatakeyama K, Kojima K, Yano M, Yano Y, Nakamura K, Nakamura-Uchiyama F, Matsushima Y, Imamura T, Onitsuka T, Asada Y, Nawa Y, Eto T, Kitamura K. Tsuruda T, et al. Circ Res. 2008 Jun 6;102(11):1368-77. doi: 10.1161/CIRCRESAHA.108.173682. Epub 2008 May 1. Circ Res. 2008. PMID: 18451339 - Role of the renin-angiotensin system in the development of abdominal aortic aneurysms in animals and humans.
Daugherty A, Rateri DL, Cassis LA. Daugherty A, et al. Ann N Y Acad Sci. 2006 Nov;1085:82-91. doi: 10.1196/annals.1383.035. Ann N Y Acad Sci. 2006. PMID: 17182925 Review. - Matrix metalloproteinases: contribution to pathogenesis, diagnosis, surveillance and treatment of abdominal aortic aneurysms.
Kadoglou NP, Liapis CD. Kadoglou NP, et al. Curr Med Res Opin. 2004 Apr;20(4):419-32. doi: 10.1185/030079904125003143. Curr Med Res Opin. 2004. PMID: 15119978 Review.
Cited by
- Alkaline ceramidase 1-mediated platelet ceramide catabolism mitigates vascular inflammation and abdominal aortic aneurysm formation.
Zhang X, Gong Z, Shen Y, Cai Z, Yang L, Zhang T, Li W, Zhao Y, Zhu S, Liu C, Wang J, Wang X, Qi R, Liu J, Lei X, Wang W, Jiang C, Fu Y, Kong W. Zhang X, et al. Nat Cardiovasc Res. 2023 Dec;2(12):1173-1189. doi: 10.1038/s44161-023-00364-1. Epub 2023 Nov 16. Nat Cardiovasc Res. 2023. PMID: 39196139 - A porcine model of thoracic aortic aneurysms created with a retrievable drug infusion stent graft mirrors human aneurysm pathophysiology.
Kenawy DM, Stafford JF, Amari F, Campbell D, Abdel-Rasoul M, Leight J, Chun Y, Tillman BW. Kenawy DM, et al. JVS Vasc Sci. 2024 Jul 2;5:100212. doi: 10.1016/j.jvssci.2024.100212. eCollection 2024. JVS Vasc Sci. 2024. PMID: 39188992 Free PMC article. - Macrophage ILF3 promotes abdominal aortic aneurysm by inducing inflammatory imbalance in male mice.
Wang ZY, Cheng J, Wang Y, Yuan HT, Bi SJ, Wang SX, Hou YM, Zhang X, Xu BH, Wang ZY, Zhang Y, Jiang WJ, Chen YG, Zhang MX. Wang ZY, et al. Nat Commun. 2024 Aug 23;15(1):7249. doi: 10.1038/s41467-024-51030-4. Nat Commun. 2024. PMID: 39179537 Free PMC article. - NINJ1 Facilitates Abdominal Aortic Aneurysm Formation via Blocking TLR4-ANXA2 Interaction and Enhancing Macrophage Infiltration.
Wu Z, Xu Z, Pu H, Ding A, Hu J, Lei J, Zeng C, Qiu P, Qin J, Wu X, Li B, Wang X, Lu X. Wu Z, et al. Adv Sci (Weinh). 2024 Aug;11(31):e2306237. doi: 10.1002/advs.202306237. Epub 2024 Jun 23. Adv Sci (Weinh). 2024. PMID: 38922800 Free PMC article. - Soluble glycoprotein VI predicts abdominal aortic aneurysm growth rate and is a novel therapeutic target.
Benson TW, Pike MM, Spuzzillo A, Hicks SM, Ali S, Pham M, Mix DS, Brunner SI, Wadding-Lee C, Conrad KA, Russell HM, Jennings C, Coughlin TM, Aggarwal A, Lyden S, Mani K, Björck M, Wanhainen A, Bhandari R, Lipworth-Elliot L, Robinson-Cohen C, Caputo FJ, Shim S, Quesada O, Tourdot B, Edwards TL, Tranter M, Gardiner EE, Mackman N, Cameron SJ, Owens AP 3rd. Benson TW, et al. Blood. 2024 Oct 17;144(16):1663-1678. doi: 10.1182/blood.2023021655. Blood. 2024. PMID: 38900973
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources